Le printemps de l’immunité innée couronné à Stockholm

Medecine/Sciences

Volumn 27, Issue 11, 2011, Pages 1019-1024

  Imler, Jean Luc ^a   Ferrandon, Dominique ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

AWARDS AND PRIZES; BIOLOGICAL MODEL; CHEMISTRY; GENETIC ASSOCIATION; GENETICS; HUMAN; IMMUNOTHERAPY; INNATE IMMUNITY; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; REVIEW; SEASON; STRUCTURE ACTIVITY RELATION;

GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; NOBEL PRIZE; SEASONS; STRUCTURE-ACTIVITY RELATIONSHIP; TOLL-LIKE RECEPTORS;

EID: 84856618668     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20112711020     Document Type: Article

References (38)

1. Anderson KV, Bokla L, Nussiein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 1985; 42: 791-8.
2. Janeway C. Evolution and revolution in immunology. Cold Spring Harbor Symposia Quant Biol 1989; 54: 1-13.
3. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991-1045.
4. Steiner H, Hultmark D, Engstrom A, et al. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 1981; 292: 246-8.
5. Dimarcq JL, Keppi E, Dunbar B, et al. Insect immunity. Purification and characterization of a family of novel inducible antibacterial proteins from immunized larvae of the dipteran Phormia terranovae and complete amino-acid sequence of the predominant member, diptericin A. Eur J Biochem 1988; 171: 17-22.
6. Engstrom Y, Kadayalil L, Sun S, et al. kB-like motifs regulate the induction of immune genes in Drosophila. J Mol Biol 1993; 232: 327-33.
7. Kappler C, Meister M, Lagueux M, et al. Insect immunity. Two 17bp repeats nesting a kB-related sequence confer inducibility to the diptericin gene and bind a polypeptide in bacteria-challenged Drosophila. EMBO J 1993; 12: 1561-8.
8. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999; 284: 1313-8.
9. Reichhart J, Georgel P, Meister M, et al. Expression and nuclear translocation of the rel/NF-kB-related morphogen dorsal during the immune response of Drosophila. CR Acad Sci (Paris) 1993; 316: 1218-24.
10. Fehlbaum P, Bulet P, Michaut L, et al. Insect immunity: septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides. J Biol Chem 1994; 269: 33159-63.
11. Lemaitre B, Nicolas E, Michaut L, et al. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86: 973-83.
12. Rutschmann S, Jung A, Hetru C, et al. The Rel protein DIF mediates the Toll-dependent antifungal response in Drosophila. Immunity 2000; 12: 569-80.
13. Hedengren M, Asling B, Dushay M, et al. Relish, a central factor in the control of humoral but not cellular immunity in Drosophila. Mol Cell 1999; 4: 1-20.
14. Lemaitre B, Kromer-Metzger E, Michaut L, et al. A recessive mutation, immune deficiency (imd), defines two distinct control pathways in the Drosophila host defense. Proc Natl Acad Sci USA 1995; 92: 9365-9.
15. Medzhitov R, Preston-Hurlburt P, Janeway C. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394-7.
16. Beutler B, Greenwald D, Hulmes JD, et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985; 316: 552-4.
17. Peppel K, Crawford D, Beutler B. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med 1991; 174: 1483-9.
18. Cerami A, Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 1988; 9: 28-31.
19. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-8.
20. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11: 443-51.
21. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-84.
22. Jin MS, Lee JO. Structures of the toll-like receptor family and its ligand complexes. Immunity 2008; 29: 182-91.
23. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-20.
24. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317: 1522-7.
25. Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol 2011; 29: 447-91.
26. Philpott DJ, Girardin SE. Nod-like receptors: sentinels at host membranes. Curr Opin Immunol 2011; 22: 428-34.
27. Yoneyama M, Fujita T. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 2008; 29: 178-81.
28. Keogh B, Parker AE. Toll-like receptors as targets for immune disorders. Trends Pharmacol Sci 2011; 32: 435-42.
29. Kasturi SP, Skountzou I, Albrecht RA, et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 2011; 470: 543-7.
30. Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010; 33: 492-503.
31. Green NM, Marshak-Rothstein A. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol 2011; 23: 106-12.
32. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-32.
33. I mler JL, Reichhart JM. Immunité innée: deux récepteurs pour détecter l’ADN bactérien. Med Sci (Paris) 2001; 17: 510-2.
34. Hoffmann JA, Dimarcq JL, Bulet P. Les peptides antibactériens inductibles des insectes. Med Sci (Paris) 1992; 8: 432-9.
35. Sibilia J. Protéine de fusion ou anticorps monoclonal: quel biomédicament choisir dans une maladie inflammatoire. Med Sci (Paris) 2009; 25: 1033-8.
36. Delneste Y, Beauvillain C, Jeannin P. Immunité naturelle: structure et fonction des Toll-like receptors. Med Sci (Paris) 2007; 23: 67-73.
37. Vavre F, Mavingui P. Les bactéries symbiotiques d’arthropodes et de nématodes: de nouvelles alliées dans le contrôle des maladies infectieuses. Med Sci (Paris) 2011; 27: 953-8.
38. e siècle. Med Sci (Paris) 201 27: 919-20.